ResearcherFirst Affiliated Hospital of Wenzhou Medical UniversityNo recent work listed

Xinwei Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5443-0215; OpenAlex author ID A5100681998. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2023: 1 paper

Papers 1

Berbamine Exerts an Anti-oncogenic Effect on Pancreatic Cancer by Regulating Wnt and DNA Damage-related Pathways. Last author DOI 10.2174/1871520622666220509174306 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bingren Hu · 1 shared paper, 2023 · strength 0.20
- Paper Berbamine Exerts an Anti-oncogenic Effect on Pancreatic Cancer by Regulating Wnt and DNA Damage-related Pathways. DOI 10.2174/1871520622666220509174306 ↗
Gang Chen · 1 shared paper, 2023 · strength 0.20
- Paper Berbamine Exerts an Anti-oncogenic Effect on Pancreatic Cancer by Regulating Wnt and DNA Damage-related Pathways. DOI 10.2174/1871520622666220509174306 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.